$1.48
-0.05-3.27%
Last update: Nov 2, 4:00 PM
GRI Bio Inc (GRI) Stock Price, Quote, News & History
GRINASDAQ
Wall Street analysts updated views on notable stocks. See changes on analyst ratings page. Price targets raised/cut, ratings maintained/changed.
You can purchase shares of GRI Bio (NASDAQ:GRI) through any online brokerage.
Other companies in GRI Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
GRI Bio has a consensus price target of $105.67.
The stock price for GRI Bio (NASDAQ: GRI) is $1.6 last updated October 29, 2026 at 7:46 PM EDT.
There are no upcoming dividends for GRI Bio.
GRI Bio does not have any upcoming earnings scheduled.
There is no upcoming split for GRI Bio.
GRI Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI...
